Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Cancer Control : Journal of the Moffitt Cancer Center|November 2, 2023
RoBERTa-Assisted Outcome Prediction in Ovarian Cancer Cytoreductive Surgery Using Operative NotesAlexandros Laios, Evangelos Kalampokis, Marios Evangelos Mamalis, et al.Medicina (Kaunas, Lithuania)|November 11, 2022
Survival and Chemosensitivity in Advanced High Grade Serous Epithelial Ovarian Cancer Patients with and without a BRCA Germline Mutation: More Evidence for Shifting the Paradigm towards Complete Surgical CytoreductionDiederick De Jong, Mohamed Otify, Inga Chen, et al.Journal of Clinical Medicine|April 12, 2025
Mapping the Advanced-Stage Epithelial Ovarian Cancer Landscape Goes Beyond Words: Two Large Language Models, Eight Tasks, One JourneyMichela Quaranta, Alexandros Laios, Charlie Rogers, et al.Journal of Clinical Medicine|December 24, 2021
The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical CytoreductionRacheal Louise Johnson, Alexandros Laios, David Jackson, et al.Cancers|February 11, 2023
Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial IntelligenceAlexandros Laios, Evangelos Kalampokis, Racheal Johnson, et al.Current Oncology (Toronto, Ont.)|February 25, 2025
Incidence and Predictors of Acute Kidney Injury Following Advanced Ovarian Cancer Cytoreduction at a Tertiary UK Centre: An Exploratory Analysis and Insights from Explainable Artificial IntelligenceElizabeth Ratcliffe, Ciara Devlin, Sarika Munot, et al.BMC Research Notes|October 28, 2015
A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging systemAlexandros Laios, Davide Volpi, Iain D C Tullis, et al.Anticancer Research|May 31, 2024
Continuity Unveiled: Evaluating Cytoreduction Outcomes for Advanced Ovarian Cancer Amidst the COVID-19 Era at an ESGO Designated Centre of ExcellenceKonstantinos Kitsos-Kalyvianakis, Konstantinos Pitsikakis, Marios Evangelos Mamalis, et al.Cancers|July 27, 2022
Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian CancerAlexandros Laios, Evangelos Kalampokis, Racheal Johnson, et al.Cancers|September 28, 2023
Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT AnalysisRacheal Louise Johnson, Subhasheenee Ganesan, Amudha Thangavelu, et al.Pageof 5